Italy Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

2018-12-01
Price :
Published : Dec-2018
No. of Pages : 45

Italy Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

Summary

GlobalData’s new report, Italy Neurology Procedures Outlook to 2025, provides key procedures data on the Italy Neurology Procedures. The report provides procedure volumes within market categories – Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Neuromodulation Procedures, Neurovascular Accessory Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Embolization Procedures and Neurovascular Thrombectomy Procedures

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

– Italy Neurology Procedures volumes by categories – Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Neuromodulation Procedures, Neurovascular Accessory Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Embolization Procedures and Neurovascular Thrombectomy Procedures.
– Projections for each of the market categories. Data is provided from 2015 and forecast to 2025.
– Develop business and investment strategies by identifying the key market categories expected to register strong growth in the near future.
– Develop market-entry and market expansion strategies.

Reasons to buy

– Develop business and investment strategies by identifying the key market segment expected to register strong growth in the near future.
– Develop market-entry and market expansion strategies.

Filed in: Pharmaceutical, Therapeutics
Publisher : GlobalData
More Reports
Title Price Buy Now

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of China. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by ......
$1995

Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2018

Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2018" provides an overview of Chagas Disease (American Trypanosomiasis) clinical trials scenario. This report provides top line data relating to the clinical trials on Chagas Disease (American Trypanosomiasis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial ......
$2500

Bruise (Contusion) Global Clinical Trials Review, H2, 2018

Bruise (Contusion) Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Bruise (Contusion) Global Clinical Trials Review, H2, 2018" provides an overview of Bruise (Contusion) clinical trials scenario. This report provides top line data relating to the clinical trials on Bruise (Contusion). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Chlamydia Infections Global Clinical Trials Review, H2, 2018

Chlamydia Infections Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Chlamydia Infections Global Clinical Trials Review, H2, 2018" provides an overview of Chlamydia Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Chlamydia Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinic......
$2500

Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2018

Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Carpal Tunnel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Carpal Tunnel Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrac......
$2500

Chorea Global Clinical Trials Review, H2, 2018

Chorea Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Chorea Global Clinical Trials Review, H2, 2018" provides an overview of Chorea clinical trials scenario. This report provides top line data relating to the clinical trials on Chorea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80......
$2500

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2018

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Chediak-Higashi Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Chediak-Higashi Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Phar......
$2500

Bulimia Nervosa Global Clinical Trials Review, H2, 2018

Bulimia Nervosa Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Bulimia Nervosa Global Clinical Trials Review, H2, 2018" provides an overview of Bulimia Nervosa clinical trials scenario. This report provides top line data relating to the clinical trials on Bulimia Nervosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2018

Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2018" provides an overview of Chlamydia trachomatis Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Chlamydia trachomatis Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDa......
$2500

Cat Allergy Global Clinical Trials Review, H2, 2018

Cat Allergy Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Cat Allergy Global Clinical Trials Review, H2, 2018" provides an overview of Cat Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Cat Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy